[1] |
Chen Y L, Wang C, Shang H C, et al. Clinical practice guidelines in China[J]. British Medical Journal, 2018, 360:j5158.
|
[2] |
陈耀龙, 元博, 孙丽娜, 等. 中国大陆临床实践指南引文分析[J]. 中国循证儿科杂志, 2013, 8(6):467-470.
|
[3] |
陈飞, 曾艳彩, 魏厚仁. 从循证医学角度分析中华眼科杂志已发表临床疗效研究论文的质量[J]. 中华眼科杂志, 2004(9):609-613.
|
[4] |
Wu T, Li Y, Bian Z, et al. Randomized trials published in some Chinese journals:How many are randomized?[J]. Trials, 2009, 10:46.
doi: 10.1186/1745-6215-10-46
URL
|
[5] |
Farquhar C M, Showell M G, Showell E A E, et al. Clinical trial registration was not an indicator for low risk of bias[J]. Journal of Clinical Epidemiology, 2017, 84:47-53.
doi: S0895-4356(16)30733-8
pmid: 28088595
|
[6] |
赵宏杰, 张俊华, 郭利平, 等. 我国高影响因子中文医学期刊发表随机对照试验注册、伦理、知情同意报告现状及质量评价分析[J]. 中国循证医学杂志, 2018, 18(7):735-739.
|
[7] |
Zhang J, Chen X, Zhu Q, et al. Methodological reporting quality of randomized controlled trials:A survey of seven core journals of orthopaedics from Mainland China over 5 years following the CONSORT statement[J]. Orthopaedics & Traumatology:Surgery & Research, 2016, 102(7):933-938.
|
[8] |
Xu L, Li J, Zhang M M, et al. Chinese authors do need CONSORT:Reporting quality assessment for five leading Chinese medical journals[J]. Contemporary Clinical Trials, 2008, 29(5):727-731.
doi: 10.1016/j.cct.2008.05.003
URL
|
[9] |
Zou Y, Li Q, Xu W. Scientific research output in orthopaedics from China and other top-ranking countries:A 10-year survey of the literature[J]. BMJ Open, 2016, 6(9):e011605.
doi: 10.1136/bmjopen-2016-011605
URL
|
[10] |
Verhagen A P, de Vet H C W, de Bie R A, et al. The Delphi list:A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus[J]. Journal of Clinical Epidemiology, 1998, 51(12):1235-1241.
pmid: 10086815
|
[11] |
Jüni P, Altman D G, Egger M. Systematic reviews in health care:Assessing the quality of controlled clinical trials[J]. British Medical Journal, 2001, 323(7303):42-46.
doi: 10.1136/bmj.323.7303.42
URL
|
[12] |
Jadad A R, Moore R A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials:Is blinding necessary?[J]. Controlled Clinical Trials, 1996, 17(1):1-12.
pmid: 8721797
|
[13] |
栾嘉. 我国医学期刊临床研究论文质量影响因素及其控制对策研究[D]. 重庆:中国人民解放军陆军军医大学, 2020:33-36.
|
[14] |
栾嘉, 邓强庭, 黄超, 等. 我国医学期刊临床研究论文质量控制策略[J]. 中国科技期刊研究, 2019, 30(12):1281-1288.
|
[15] |
Tan A C, Jiang I, Askie L, et al. Prevalence of trial registration varies by study characteristics and risk of bias[J]. Journal of Clinical Epidemiology, 2019, 113:64-74.
doi: 10.1016/j.jclinepi.2019.05.009
URL
|
[16] |
汪勤俭, 郭建秀, 栾嘉, 等. 84篇因学术不端退稿稿件追踪分析与思考[J]. 编辑学报, 2012, 24(2):131-133.
|
[17] |
Tian J H, Zhang J, Ge L, et al. The methodological and reporting quality of systematic reviews from China and the USA are similar[J]. Journal of Clinical Epidemiology, 2017, 85:50-58.
doi: 10.1016/j.jclinepi.2016.12.004
URL
|
[18] |
Farquhar C M, Showell M G, Showell E A E, et al. Clinical trial registration in fertility trials:A case for improvement?[J]. Human Reproduction, 2017, 32(9):1827-1834.
doi: 10.1093/humrep/dex251
URL
|
[19] |
Zeng N, Zou C L, He Z Y, et al. Systematic review on the reporting quality of randomized controlled trials in patients with hepatitis B or C in China[J]. International Journal of Infectious Diseases, 2018, 67:58-64.
doi: S1201-9712(17)30293-X
pmid: 29138012
|
[20] |
李幼平, 李静, 刘雪梅. 建立CONSORT声明中国传播协作网提高中国临床试验报告质量[J]. 中国循证医学杂志, 2005, 5(8):591-592.
|
[21] |
Hays M, Andrews M, Wilson R, et al. Reporting quality of randomised controlled trial abstracts among high-impact general medical journals:A review and analysis[J]. BMJ Open, 2016, 6(7):e011082.
doi: 10.1136/bmjopen-2016-011082
URL
|
[22] |
尚淑贤, 颜艳, 吴晓初. 中文临床医学期刊随机对照临床试验摘要报告质量评估[J]. 中国科技期刊研究, 2017, 28(12):1121-1127.
|
[23] |
杨智荣, 孙凤, 詹思延. 偏倚风险评估系列:(一)概述[J]. 中华流行病学杂志, 2017, 38(7):983-987.
|
[24] |
刘雪梅, 张凌之, 李幼平, 等. 我国医学期刊实施发表伦理举措之一:应用报告指南[J]. 中国科技期刊研究, 2012, 23(5):759-762.
|
[25] |
李娜, 李洁, 孙菲, 等. 我国医学期刊编辑对医学研究报告规范的认知度[J]. 中国科技期刊研究, 2019, 30(4):358-363.
|
[26] |
Kotz D, Tugwell P, Knottnerus J A. How to promote transparency and accountability in clinical and behavioral research[J]. Journal of Clinical Epidemiology, 2016, 70:275.
doi: 10.1016/j.jclinepi.2015.07.001
|
[27] |
中国科学技术协会. 中国科技期刊发展蓝皮书(2017)[M]. 北京: 科学出版社,2018.
|
[28] |
Jia Y X, Wen J J, Qureshi R, et al. Effect of redundant clinical trials from mainland China evaluating statins in patients with coronary artery disease:Cross sectional study[J]. British Medical Journal, 2021, 372:n48.
|
[29] |
李艳. 我国学术期刊评价体系现状及发展趋势[J]. 中国科技期刊研究, 2015, 26(5):507-512.
|
[30] |
李海燕, 安静, 夏旭. 医学期刊评价指标体系的构建[J]. 科技管理研究, 2009, 29(11):151-152.
|
[31] |
石朝云, 游苏宁, 蔡丽枫, 等. 医学期刊综合质量评价的实践与思考[J]. 中国科技期刊研究, 2008, 19(6):941-944.
|
[32] |
刘小纬, 孙政, 骆华伟, 等. 引文分析法结合德尔菲法在医学期刊评价中的应用[J]. 浙江实用医学, 2015, 20(5):388-391.
|
[33] |
陈丽, 陈坤. 应用加权秩和比法作医学期刊学术质量综合评价的研究[J]. 浙江预防医学, 2015, 27(9):960-962,965.
|
[34] |
刘筱敏. 学术交流视角下中国科技期刊发展的思考[J]. 中国科技期刊研究, 2020, 31(10):1146-1152.
|
[35] |
李幼平, 杜亮, 刘雪梅. 推进临床试验注册和规范化报告,从入口到出口把关临床试验质量[J]. 中国循证医学杂志, 2010, 10(1):1-2.
|
[36] |
杜亮, 李幼平, 张永刚. 强化两端,健全高质量证据生产的全程质控[J]. 中国循证医学杂志, 2017, 17(11):1241-1244.
|